onr:"swepub:oai:DiVA.org:uu-272042"
Search: onr:"swepub:oai:DiVA.org:uu-272042" > Chronic obstructive...
- 1 of 1
- Previous record
- Next record
- To hitlist
Chronic obstructive pulmonary disease in patients with atrial fibrillation : Insights from the ARISTOTLE trial
-
- Durheim, Michael T. (author)
- Duke Clin Res Inst, Durham, NC USA.;Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC USA.
-
- Cyr, Derek D. (author)
- Duke Clin Res Inst, Durham, NC USA.
-
- Lopes, Renato D. (author)
- Duke Clin Res Inst, Durham, NC USA.;Duke Univ, Med Ctr, Div Cardiol, Durham, NC 27710 USA.
- show more...
- show less...
- Duke Clin Res Inst, Durham, NC USA;Duke Univ, Med Ctr, Div Pulm Allergy & Crit Care Med, Durham, NC USA. Duke Clin Res Inst, Durham, NC USA. (creator_code:org_t)
- Elsevier BV, 2016
- 2016
- English.
- In: International Journal of Cardiology. - : Elsevier BV. - 0167-5273 .- 1874-1754. ; 202, s. 589-594
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Background: Comorbid chronic obstructive pulmonary disease (COPD) is associated with poor outcomes among patients with cardiovascular disease. The risks of stroke and mortality associated with COPD among patients with atrial fibrillation are not well understood. Methods: We analyzed patients from ARISTOTLE, a randomized trial of 18,201 patients with atrial fibrillation comparing the effects of apixaban versus warfarin on the risk of stroke or systemic embolism. Using Cox proportional hazards models, we assessed the associations between comorbid COPD and risk of stroke or systemic embolism and of mortality, adjusting for treatment allocation, smoking history and other risk factors. Results: COPD was present in 1950 (10.8%) of 18,134 patients with data on pulmonary disease history. After multivariable adjustment, COPD was not associated with risk of stroke or systemic embolism (adjusted HR 0.85 [95% CI 0.60, 1.21], p = 0.356). However, COPD was associated with a higher risk of all-cause mortality (adjusted HR 1.60 [95% CI 1.36, 1.88], p < 0.001) and both cardiovascular and non-cardiovascular mortality. The benefit of apixaban over warfarin on stroke or systemic embolism was consistent among patients with and without COPD (HR 0.92 [95% CI 0.52, 1.63] versus 0.78 [95% CI 0.65, 0.95], interaction p = 0.617). Conclusions: COPD was independently associated with increased risk of cardiovascular and non-cardiovascular mortality among patients with atrial fibrillation, but was not associated with risk of stroke or systemic embolism. The effect of apixaban on stroke or systemic embolism in COPD patients was consistent with its effect in the overall trial population.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Kardiologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)
Keyword
- COPD
- Atrial fibrillation
- Anticoagulation
- Mortality
- Stroke
Publication and Content Type
- ref (subject category)
- art (subject category)
Find in a library
- International Journal of Cardiology (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Durheim, Michael ...
- Cyr, Derek D.
- Lopes, Renato D.
- Thomas, Laine E.
- Tsuang, Wayne M.
- Gersh, Bernard J ...
- show more...
- Held, Claes
- Wallentin, Lars
- Granger, Christo ...
- Palmer, Scott M.
- Al-Khatib, Sana ...
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Cardiac and Card ...
- Articles in the publication
- International Jo ...
- By the university
- Uppsala University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
